Cantitate/Preț
Produs

Congenital Bleeding Disorders

Editat de Akbar Dorgalaleh
en Limba Engleză Paperback – 29 dec 2024
The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (2) 71401 lei  38-45 zile
  Springer International Publishing – 25 dec 2018 71401 lei  38-45 zile
  Springer – 29 dec 2024 99953 lei  38-45 zile
Hardback (1) 141139 lei  38-45 zile
  Springer International Publishing – 28 dec 2023 141139 lei  38-45 zile

Preț: 99953 lei

Preț vechi: 105214 lei
-5% Nou

Puncte Express: 1499

Preț estimativ în valută:
17687 20740$ 15533£

Carte tipărită la comandă

Livrare economică 02-09 februarie 26

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031431586
ISBN-10: 3031431588
Pagini: 480
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.81 kg
Ediția:Second Edition 2023
Editura: Springer

Cuprins

 An Overview of Hemostasis.- Congenital Bleeding Disorders: Diagnosis and Management.- von Willebrand disease: an update on diagnosis and treatment.- Hemophilia A, Diagnosis and Management.- Hemophilia B, Diagnosis and Management.- Congenital fibrinogen disorders, diagnosis, and management.- Congenital Prothrombin Deficiency: Diagnosis and Management.- Congenital Factor V Deficiency.- Combined Factor V and Factor VIII Deficiency, Diagnosis and Management.- Congenital Factor VII Deficiency, Diagnosis and Management.- Vitamin K-dependent Coagulation Factors Deficiency, Diagnosis and Management.- Congenital Factor X deficiency, Diagnosis and Management.- Congenital Factor XI Deficiency.- Congenital Factor XIII Deficiency, Diagnosis and Management.- Glanzmann Thrombasthenia.- Bernard-Soulier Syndrome, Diagnosis and Management.- Gray Platelet Syndrome (GPS).

 

Notă biografică

Akbar Dorgalaleh, hematologist and scientific researcher in the field of congenital bleeding disorders in the Department of Hematology and Blood Transfusion, Iran University of Medical Sciences (IUMS). Dr. Dorgalaleh’s primary interest is the diagnosis and management of congenital bleeding disorders, and he has a special interest in congenital factor XIII deficiency. He acts as a reviewer for several international journals in the field of Hematology and to date has authored about 100 papers that cover all the congenital bleeding disorders, including hemophilia, rare bleeding disorders, and inherited platelet function disorders. He has reported the clinical, laboratory, and molecular characteristics of a very large number of patients with congenital bleeding disorders.  

Textul de pe ultima copertă

This significantly updated new edition describes in detail the clinical presentations, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders. The exceptional attention to rarer conditions is of particular importance given the considerable risk of overlooking them during diagnosis, with potential consequences for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value tohematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees.


Caracteristici

Offers detailed assistance in the diagnosis and management of bleeding disorders Includes extensive coverage of rare disorders and the challenges that they pose Provides up-to-date guidance on use of the latest treatment options and new products